Covis Pharma’s statement to The Times about Makena
The following combines several statements from Covis Pharma sent via email. It has been organized for clarity.Covis Pharma’s response:Makena is the only FDA-approved therapy to reduce the…
Browsing Tag
Pharmas
Emcure Pharma’s Rs 5,000 cr-IPO to hit market early next month
Mumbai: Emcure Pharmaceuticals has received regulatory approvals for its draft red herring prospectus and will shortly be filing the RHP for the Rs 5,000-crore initial share sale, which will…
Human review: Shefali Shah gives a vicious performance in series about Big Pharma’s…
The Disney+ Hotstar series Human is a bombastic indictment of the pharmaceutical industry and private healthcare’s ravenous appetite for profit at the cost of human lives. A pharma giant…
OKYO Pharma announces issuance of U.S. Patent No. 11,197,906 covering OKYO Pharma’s…
LONDON and BOSTON, Dec. 14, 2021 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; OTCQB: EMMLF), a biotechnology company focused on the discovery and development of novel molecules to…
Torrent Pharma’s positive India show infuses confidence
Shares of Torrent Pharmaceuticals Ltd have gained more than 10% over the last one week. The renewed investor confidence is led by expectations of a strong growth trajectory in…
Love Pharma’s Acquisition Will Offer Exclusive Partnership and License with World…
NEW YORK, NY, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Love Pharma Inc. (CSE: LUV) (FSE: G1Q0) continues to prioritize the necessity for clinical validation as a vital step in bringing its…
Sun Pharma’s 2 US arms to pay USD 85 mn in settlement pacts over antritrust…
New Delhi: Sun Pharmaceutical Industries on Friday said two of its US-based subsidiaries have inked settlement pacts with the direct purchaser plaintiffs in the matter of generic…
European Patent Grant Strengthens Small Pharma’s Ketamine-Based Patent Portfolio for…
LONDON, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a neuropharmaceutical company focused on psychedelic-assisted…
Stephen Ross, M.D., Chair of Reset Pharma’s Scientific Advisory Board to Deliver…
NEW YORK, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Reset Pharmaceuticals, Inc. (Reset Pharma) announced today that Stephen Ross, M.D., Chair of Reset Pharma’s Scientific Advisory Board, will…
Purdue Pharma’s Creditors Overwhelmingly Endorse Bankruptcy Plan
A huge majority of more than 120,000 creditors of Purdue Pharma have voted to approve the company’s bankruptcy plan, a key step toward the eventual release of more than $4.5 billion dollars…